BeFluBu vs FluBuRux Conditioning in Haploidentical HCT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BeFluBu vs FluBuRux Conditioning in Haploidentical HCT — Stella

Home/Acute Lymphoblastic Leukemia/

View on ClinicalTrials.gov

Recruiting

Back to Acute Lymphoblastic Leukemia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Russia

RM Gorbacheva Research Institute, Saint Petersburg

Key details

Phase

Safety & dosing

Sponsor

St. Petersburg State Pavlov Medical University

Enrollment target

~220 participants

Started

June 2024

Primary completion

June 2028

Age range

18 Years – 75 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.